Organ transplantation
Conditions
Interventions
chronic rejectional group:10ml peripheral blood sample was collectd from each patient and then analysed by Proteomics and genomics
Control group:10ml peripheral blood sample was collectd from each patient and then analysed by Proteomics and genomics
Experimental group:10ml peripheral blood sample was collectd from each patient and then analysed by Proteomics and genomics
Sponsors
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Individuals who were fully informed, signed informed consent voluntarily and had good compliance; 2. Individuals who, for at least 1 year prior to enrollment; 3. Patients who had not taken immunosuppressive medications and had stable graft function.
Exclusion criteria
Exclusion criteria: 1. Patient with active infection; 2. Patient with orbital malignant tumor; 3. Patient with serious disease of critical organ.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expression of related genes;Expression of related protein; | — |
Countries
China
Contacts
Public ContactZhonghua Chen
Outcome results
None listed